Optimizing Care for Cancer Survivors With Depression: Project 3

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Apr 9, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Optimizing Care for Cancer Survivors With Depression: Project 3," is looking into different ways to help cancer survivors who are dealing with depression. The study will compare two treatment methods: one group will use a mobile app called "Moodivate" to manage their depression, while another group will have online therapy sessions with a mental health professional. About two-thirds of the participants will use the app, and if it’s not enough for them, they may also receive telehealth treatment. The study will last for about 24 weeks, during which participants will answer questionnaires to track their mood and experiences.

To be eligible for this trial, participants need to be at least 18 years old, have survived cancer, and currently show signs of depression. They should not be receiving any other treatment for depression at the moment and must be comfortable using the app or participating in online sessions. While this study aims to improve support for cancer survivors facing emotional challenges, participants should be aware of some risks, such as feeling frustrated or experiencing a temporary increase in emotional distress.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age 18+
• • cancer survivor
• • current elevated depressive symptoms defined per ASCO as a PHQ-9 score ≥ 8
• • not currently receiving psychosocial depression treatment
• • have the ability to complete treatment via telehealth and use Moodivate
• • have a valid e-mail address or text message access (for assessments)
• • English fluency
• Exclusion Criteria:
• • - Current suicidal ideation at final eligibility screening (PHQ-9 item 9 ≥1)